Approval · Notice of Compliance 17422 · 2015
BUSPIRONE: Notice of Compliance 17422
Issued October 27, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17422
- Date
- October 27, 2015
- Company
- Sanis Health Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BUSPIRONE | 02447851 | Cancelled Post Market |
Medicinal ingredients
- BUSPIRONE HCL 10 MG per TAB